Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $4.12

Daily Change: +$0.03 / 0.73%

Daily Range: $4.06 - $4.21

Market Cap: $429,036,544

Daily Volume: 912,314

Performance Metrics

1 Week: 2.99%

1 Month: -15.02%

3 Months: 24.02%

6 Months: 19.36%

1 Year: 98.56%

YTD: 8.40%

About Larimar Therapeutics, Inc. (LRMR)

Get the full story on Larimar Therapeutics, Inc. (LRMR). Price: 4.12, daily change: +$0.03 / 0.73%. Market cap: 429,036,544. Performance from YTD to 1-year is available.

Company Details

Employees: 71

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

PRA Group, Inc. (PRAA)

NACCO Industries, Inc. (NC)

FreeCast, Inc. (CAST)

EMCOR Group, Inc. (EME)

TrustCo Bank Corp NY (TRST)